Clinical Trial Update: Multiple Ascending Dose of BMS-911543 [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update for multiple ascending dose of BMS-911543 has been terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• BMS-911543

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2019-05-21